ResMed Inc. Adopts Clearstone FTO to Manage Patent Clearance

Leader in respiratory disease treatment implements pioneering freedom-to-operate management platform

‍

Palo Alto, CA - ClearstoneIP, developer of the first web platform dedicated to managing patent clearance, today announced that multi-national healthcare company ResMed Inc. has entered into an agreement to use the Clearstone FTO software to manage its freedom-to-operate and patent clearance efforts. ResMed (NYSE: RMD, ASX: RMD) develops innovative solutions that treat and keep people out of the hospital. Its cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases in more than 120 countries. [Quote from Rory?]"We're thrilled to work with ResMed in setting the standard for accelerated, responsible innovation," said Gabe Sukman, CEO of ClearstoneIP. "With hundreds of engineers and a workforce divided across several countries, Clearstone FTO's consolidated workflow platform will help ResMed's legal team manage the critical task of patent clearance."

‍

About ResMed Inc.

‍

To find out more about ResMed, please visit ResMed.com

‍

About ClearstoneIP, Inc.

‍

Founded in 2013 by patent attorneys in response to a dearth of modern best practices in the freedom-to-operate arena, ClearstoneIP is setting the standard for patent diligence and risk mitigation. Innovators worldwide are using the Clearstone FTO platform to manage, collaborate in, and perform efficient patent clearance through a purpose-built web application. ClearstoneIP is based in the San Francisco Bay Area. For more information, please visit www.clearstoneip.com.